RYK Gene Expression Associated with Drug Response Variation of Temozolomide and Clinical Outcomes in Glioma Patients

Temozolomide (TMZ) chemotherapy is an important tool in the treatment of glioma brain tumors. However, variable patient response and chemo-resistance remain exceptionally challenging. Our previous genome-wide association study (GWAS) identified a suggestively significant association of SNP rs4470517...

Descripción completa

Detalles Bibliográficos
Autores principales: Gonzalez, Ricardo D., Small, George W., Green, Adrian J., Akhtari, Farida S., Havener, Tammy M., Quintanilha, Julia C. F., Cipriani, Amber B., Reif, David M., McLeod, Howard L., Motsinger-Reif, Alison A., Wiltshire, Tim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10220703/
https://www.ncbi.nlm.nih.gov/pubmed/37242509
http://dx.doi.org/10.3390/ph16050726

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10220703/
https://www.ncbi.nlm.nih.gov/pubmed/37242509
http://dx.doi.org/10.3390/ph16050726

Ejemplares similares